Impact of introducing human immunodefi ciency virus testing, treatment and care in a tuberculosis clinic in rural Kenya

International Journal of Tuberculosis and Lung Disease

Volumn 14, Issue 5, 2010, Pages 611-615

  Huerga, H ^a   Spillane, H ^a   Guerrero, W ^a   Odongo, A ^b   Varaine, F ^a  

^a MÉDECINS SANS FRONTIÈRES   (Switzerland)

^b National Tuberculosis Programme   (Kenya)

Author keywords

ART; HIV; Integration; One stop; Tuberculosis

Indexed keywords

ANTIRETROVIRUS AGENT; COTRIMOXAZOLE;

ANTIBIOTIC PROPHYLAXIS; ARTICLE; DIAGNOSTIC TEST; HEALTH PROGRAM; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTEGRATED HEALTH CARE SYSTEM; INTERVENTION STUDY; KENYA; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; PATIENT CARE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TREATMENT OUTCOME; TUBERCULOSIS CONTROL;

ANTI-HIV AGENTS; ANTI-INFECTIVE AGENTS; DELIVERY OF HEALTH CARE, INTEGRATED; HIV INFECTIONS; HUMANS; KENYA; PATIENT CARE; RETROSPECTIVE STUDIES; RURAL HEALTH SERVICES; TREATMENT OUTCOME; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION; TUBERCULOSIS;

EID: 77950887690     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. World Health Organization. Global tuberculosis control: epidemiology, strategy, f nancing. WHO report 2009. WHO/HTM/TB/2009.411. Geneva, Switzerland: WHO, 2009: 1-303.
2. National AIDS and STI Control Programme. Kenya AIDS indicator survey 2007: preliminary report. Nairobi, Kenya: Ministry of Health, 2008: pp 1-27.
3. National AIDS and STI Control Council. Kenya HIV/AIDS data booklet. Nairobi, Kenya: NACC, 2005: pp 1-61.
4. Reid A, Scano F, Getahun H, et al. Towards universal access to HIV prevention, treatment, care and support: the role of tuberculosis/HIV collaboration. Lancet Infect Dis 2006; 6: 483-495. (Pubitemid 44109811)
5. World Health Organization. Interim policy on collaborative TB/HIV activities. WHO/HTM/TB/2004.330. WHO/HTM/HIV/2004.1 Geneva, Switzerland: WHO, 2004: 1-14.
6. Chakaya J M, Mansoer J R, Scano F, et al. National scale-up on HIV testing and provision of HIV care to tuberculosis patient in Kenya. Int J Tuberc Lung Dis 2008; 12: 424-429. (Pubitemid 351507256)
7. Bwire R, Nagelkerke N, Borgdorff M. Finding patients eligible for antiretroviral therapy using TB services as entry point for HIV treatment. Trop Med Int Health 2006; 11: 1567-1575. (Pubitemid 44450562)
8. World Health Organization. Treatment of tuberculosis: guidelines for national programmes. WHO/CDS/TB/2003.313. Geneva, Switzerland: WHO, 2003: 1-108.
9. Coetzee D, Hilderbrand K, Goemaere E, Matthys F, Boelaert M. Integrating tuberculosis and HIV care in the primary care setting in South Africa. Trop Med Int Health 2004; 9: 11-15. (Pubitemid 38833344)
10. Gasana M, Vandebriel G, Kabanda G, et al. Integrating tuberculosis and HIV care in rural Rwanda. Int J Tuberc Lung Dis 2008; 12 (Suppl 1): S39-S43. (Pubitemid 351361917)
11. Zachariah R, Spielmann M P, Harries A D, Salaniponi F L. Voluntary counselling, HIV testing and sexual behaviour among patients with tuberculosis in a rural district of Malawi. Int J Tuberc Lung Dis 2003; 7: 65-71. (Pubitemid 36427033)
12. Van't Hoog A H, Onyango J, Agaya J, et al. Evaluation of TB and HIV services prior to introducing TB-HIV activities in two rural districts in western Kenya. Int J Tuberc Lung Dis 2008; 12 (Suppl 1): S32-S38. (Pubitemid 351361916)
13. Wiktor S Z, Sassan Marokro M, Grant A D, et al. Eff cacy of trimethoprim-sulphamethoxazole prophylaxis to decrease morbidity and mortality in HIV-1 infected patients with tuberculosis in Abidjan, Cote d'Ivoire: a randomized control trial. Lancet 1999; 353: 1469-1475.
14. Harris J B, Hatwiinda S M, Randels K M, et al. Early lessons from the integration of tuberculosis and HIV services in primary care centers in Lusaka, Zambia. Int J Tuberc Lung Dis 2008; 12: 773-779.
15. Friedland G, Harries A, Coetzee D. Implementation issues in tuberculosis/HIV program collaboration and integration: 3 case studies. J Infect Dis 2007; 196 (Suppl 1): S114-S123. (Pubitemid 47206090)
16. Gandhi N R, Moll A P, Lalloo U, et al. Successful integration of tuberculosis and HIV treatment in rural South Africa: the Sizonq'oba study. J Acquir Immune Def c Syndr 2009; 50: 37-43.
17. Manosuthi W, Chottanapand S, Thongyen S, Chaovavanich A, Sungkanuparph S. Survival rate and risk factors of mortality among HIV/tuberculosis-coinfected patients with and without antiretroviral therapy. J Acquir Immune Def c Syndr 2006; 43: 42-46. (Pubitemid 44306486)
18. Harries A D, Zachariah R, Lawn S D. Providing HIV care for co-infected tuberculosis patients: a perspective from sub-Saharan Africa. Int J Tuberc Lung Dis 2009; 13: 6-16.
19. Sanguanwongse N, Cain K P, Suriya P, et al. Antiretroviral therapy for HIV-infected tuberculosis patients saves lives but needs to be used more frequently in Thailand. J Acquir Immune Def c Syndr 2008; 48: 181-189.
20. Daniel O J, Alaousa O K. Treatment outcome of TB/HIV positive and TB/HIV negative patients on directly observed treatment, short course (DOTS) in Sagamu, Nigeria. Niger J Med 2006; 15: 222-226.
21. Zachariah R, Spielmann M P, Chinji C, et al. Voluntary counselling, HIV testing and adjunctive cotrimoxazole reduces mortality in tuberculosis patients in Thyolo, Malawi. AIDS 2003; 17: 1079-1081. (Pubitemid 36549718)